SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 71 filers reported holding SERES THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.53 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,941 | -50.9% | 85,689 | -1.1% | 0.00% | – |
| Q2 2023 | $415,039 | +73.0% | 86,647 | +104.8% | 0.00% | – |
| Q1 2023 | $239,858 | +7.7% | 42,303 | +6.4% | 0.00% | – |
| Q4 2022 | $222,673 | -11.6% | 39,763 | +1.5% | 0.00% | – |
| Q3 2022 | $252,000 | +152.0% | 39,174 | +33.6% | 0.00% | – |
| Q2 2022 | $100,000 | -51.7% | 29,324 | +1.0% | 0.00% | – |
| Q1 2022 | $207,000 | -14.5% | 29,045 | -0.2% | 0.00% | – |
| Q4 2021 | $242,000 | +19.8% | 29,110 | +0.1% | 0.00% | – |
| Q3 2021 | $202,000 | -45.6% | 29,074 | +87.0% | 0.00% | – |
| Q2 2021 | $371,000 | +26.2% | 15,549 | +9.3% | 0.00% | – |
| Q1 2021 | $294,000 | -18.6% | 14,230 | -3.4% | 0.00% | – |
| Q4 2020 | $361,000 | +98.4% | 14,732 | +129.2% | 0.00% | – |
| Q3 2020 | $182,000 | +435.3% | 6,427 | -11.2% | 0.00% | – |
| Q2 2020 | $34,000 | +70.0% | 7,238 | +31.4% | 0.00% | – |
| Q1 2020 | $20,000 | -23.1% | 5,508 | -27.3% | 0.00% | – |
| Q4 2019 | $26,000 | +8.3% | 7,580 | +24.3% | 0.00% | – |
| Q3 2019 | $24,000 | +140.0% | 6,097 | +80.3% | 0.00% | – |
| Q2 2019 | $10,000 | -56.5% | 3,381 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +53.3% | 3,381 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -42.3% | 3,381 | 0.0% | 0.00% | – |
| Q3 2018 | $26,000 | -10.3% | 3,381 | 0.0% | 0.00% | – |
| Q2 2018 | $29,000 | +16.0% | 3,381 | 0.0% | 0.00% | – |
| Q1 2018 | $25,000 | -47.9% | 3,381 | -29.3% | 0.00% | – |
| Q4 2017 | $48,000 | -50.0% | 4,780 | -19.4% | 0.00% | – |
| Q3 2017 | $96,000 | +60.0% | 5,928 | +12.0% | 0.00% | – |
| Q2 2017 | $60,000 | +1.7% | 5,293 | 0.0% | 0.00% | – |
| Q1 2017 | $59,000 | +13.5% | 5,293 | 0.0% | 0.00% | – |
| Q4 2016 | $52,000 | +48.6% | 5,293 | +83.9% | 0.00% | – |
| Q3 2016 | $35,000 | -58.3% | 2,878 | 0.0% | 0.00% | – |
| Q2 2016 | $84,000 | +110.0% | 2,878 | +84.0% | 0.00% | – |
| Q1 2016 | $40,000 | -27.3% | 1,564 | 0.0% | 0.00% | – |
| Q4 2015 | $55,000 | – | 1,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |